📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-30 18:18
112 analysed today
FollowTelegram
112
Today
149,513
All-time analysed
42,888
Positive
6,650
Negative
91,302
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
38 announcements match the current filters (relevance ≥ 5).
DCM Shriram Commissions 100 TPD Aluminium Chloride & 133 TPD Calcium Chloride Plants at Bharuch
DCM Shriram has commissioned two chemical plants at Jhagadia near its Bharuch Caustic Soda facilities on September 30, 2026. A 100 TPD Aluminium Chloride plant has been commissioned, raising the company's total capacity in this product to 250 TPD. Additionally, Line 1 of a Calcium Chloride plant with 133 TPD capacity has commenced operations, with a matching 133 TPD Line 2 targeted for commissioning in October 2026. These downstream additions consume chlorine and hydrochloric acid internally, improving chemical segment integration.
Confidence: HIGH
What changedDCM Shriram operationalized a new 100 TPD Aluminium Chloride facility and the first 133 TPD line of its Calcium Chloride plant in Bharuch.
Why it mattersThe units enable direct downstream integration of chlorine and hydrochloric acid, boosting value addition and insulating margins against chlor-alkali cycle volatility.
Aluminium Chloride Capacity Added: 100 TPDTotal Aluminium Chloride Capacity: 250 TPDCalcium Chloride Line 1 Capacity: 133 TPDCommissioning Date: 30th September 2026
📅 Short termMarginal immediate earnings impact, but operational progress will be monitored alongside the prompt commissioning of Line 2 in October 2026.
📈 Long termEnhances margin resilience by captive consumption of chlorine and hydrochloric acid, strengthening the Chemicals division's competitive positioning.
⚠ Risk flags
- Ramp-up execution risk and market absorption of expanded output
- Commissioning timeline risk for Calcium Chloride Line 2
Key Highlights
Commissioned a 100 TPD Aluminium Chloride plant on 30th September 2026
Total Aluminium Chloride capacity increases to 250 TPD
Commissioned Line 1 of Calcium Chloride plant with 133 TPD capacity
Line 2 of Calcium Chloride (133 TPD) expected to be commissioned in October 2026
👀 What to Watch
Track the ramp-up of the newly commissioned lines and the scheduled October 2026 commissioning of Calcium Chloride Line 2 in upcoming quarterly operational updates.
DCM Shriram Commissions Main Aluminium Extrusion Plant at Kota Unit
DCM Shriram Limited has announced the successful commissioning of its Main Aluminium Extrusion Plant at its Kota Unit on September 1, 2026. This project stems from the Board approval originally granted on October 30, 2024. In addition, the company noted that the adjacent Surface Finish Plants are currently in the process of installation and commissioning. This commissioning supports the company's Fenesta building systems division in expanding its aluminium windows and facade offerings.
Confidence: HIGH
What changedDCM Shriram has moved its Main Aluminium Extrusion Plant at Kota from construction to operational status.
Why it mattersEnables backward integration and supports higher product diversification into aluminium facades and windows for the Fenesta brand.
Commissioning date: 1st September 2026Board approval date: 30th October 2024Extrusion plant capacity: not disclosedProject capex: not disclosed
📅 Short termOperational ramp-up will proceed over coming quarters; full commercial benefits will reflect once surface finishing lines are operational.
📈 Long termStrengthens value-added manufacturing integration and wallet share in the premium building materials market under the Fenesta business.
⚠ Risk flags
- Execution risk on pending installation of Surface Finish Plants
- Capacity utilization and market absorption rate for extruded products
Key Highlights
Commissioned Main Aluminium Extrusion Plant at Kota Unit on 1st September 2026 at 10:30 a.m.
Project stems from Board approval originally granted on 30th October 2024
Associated Surface Finish Plants are in the process of installation and commissioning
Specific capex and production capacity were not disclosed in the filing
👀 What to Watch
Track the commissioning timeline of the remaining Surface Finish Plants and monitor volume ramp-up for Fenesta's aluminium systems in upcoming quarterly results.
DCM Shriram Q1 FY27: ₹1,000 Cr Capex Planned; Demerger Application Expected This Financial Year
DCM Shriram's Q1 FY27 earnings call highlighted a resilient performance despite global supply chain volatility and uneven monsoons. The company plans a ₹1,000 Cr capex for the current year, following ₹450 Cr spent on recent acquisitions. Management confirmed they are aggressively pursuing a business demerger, with plans to file the application within this financial year. While the Bioseed segment faced a 15-20% sowing lag, the Chemicals segment is expanding with new downstream projects (Aluminium and Calcium Chloride) set for Q2 commissioning.
Confidence: HIGH
What changedThe company provided a clearer timeline for its demerger process (application this FY) and quantified its FY27 capex commitment at ₹1,000 Cr.
Why it mattersThe demerger is a key catalyst for value unlocking across its diverse business segments, while the ₹1,000 Cr capex (~7.5% of TTM revenue) signals continued focus on downstream chemical expansion.
Planned FY27 Capex: ₹1,000 CrCapex vs TTM Revenue: ~7.5%Debt to EBITDA: 1.1xRecent Acquisition Value: ₹450 CrPeak Renewable Capacity: 176 MWSugar Price: ₹4,450 per quintal
📅 Short termThe stock may react to the clarity on the demerger timeline and the impact of reinstated PVC import duties on the Vinyl segment's profitability.
📈 Long termStructural growth is tied to the successful execution of the ₹1,000 Cr capex and the potential re-rating of individual business units post-demerger.
⚠ Risk flags
- Volatility in global PVC prices
- Regulatory uncertainty regarding ethanol blending feedstocks
- Weather-related risks impacting the Bioseed and Sugar segments
Key Highlights
Planned capital expenditure of approximately ₹1,000 Cr for the current financial year.
Management intends to file the formal demerger application with the government within FY27.
Debt-to-EBITDA ratio remains healthy at 1.1x, despite recent acquisitions totaling ₹450 Cr.
Peak renewable energy capacity is projected to reach 176 MW across Bharuch and Kota sites.
Bioseed business saw a 15-20% reduction in sowing in key regions due to patchy monsoon distribution.
👀 What to Watch
Watch for the formal filing of the demerger scheme and the successful commissioning of the downstream chemical projects in Q2 FY27 to gauge margin improvements.
Q1 FY27: 9% Revenue Growth to ₹3,564 Cr; Adjusted PAT Rises 29% to ₹147 Cr
DCM Shriram reported a resilient Q1 FY27 with consolidated revenue growing 9% YoY to ₹3,564 crore, primarily driven by a 33% surge in the Chemicals segment and 22% growth in Fenesta Building Systems. While reported PAT reached ₹693 crore, it was significantly boosted by a ₹474.3 crore one-time tax adjustment and ₹79.4 crore in exceptional gains from land/JV sales. Excluding these, normalized PAT stood at ₹147 crore, up 29% from ₹114 crore in the previous year. The Chemicals & Vinyl segment showed strong operational improvement with a 30% increase in PBDIT.
Confidence: HIGH
What changedThe company has transitioned from a heavy capex phase to the commissioning phase of its chemical expansion projects while benefiting from a significant one-time tax settlement.
Why it mattersThe strong performance in Chemicals and Fenesta offsets volatility in the Agri and Sugar segments, demonstrating the benefit of the company's diversified business model and vertical integration.
Net Revenue (Q1 FY27): ₹3,564 croreAdjusted PAT: ₹147 croreTax Adjustment (One-time): ₹474.3 croreChemicals Revenue Growth: 33%Revenue vs TTM Revenue: ~26.9%
📅 Short termThe stock may see positive sentiment due to strong operational growth in core segments, although the market will likely strip out the one-time tax gain to assess core profitability.
📈 Long termLong-term value creation depends on the successful ramp-up of new chemical capacities and the continued expansion of the high-margin Fenesta retail network.
⚠ Risk flags
- Volatility in coal prices impacting Chloro-Vinyl margins
- Regulatory uncertainty regarding ethanol feedstock pricing
- Erratic monsoon impact on rural agri-input demand
Key Highlights
Net Revenue increased 9% YoY to ₹3,564 crore, representing ~27% of TTM revenue.
Chemicals segment revenue grew 33% YoY, supported by healthy domestic caustic soda demand.
Reported PAT of ₹693 crore includes a ₹474.3 crore favorable tax adjustment from previous years.
Fenesta Building Systems delivered 22% YoY revenue growth driven by volume.
PBDIT increased 12% YoY to ₹364 crore, with Chemicals & Vinyl segment PBDIT up 30%.
👀 What to Watch
Investors should monitor the commissioning and capacity ramp-up of the Aluminum Chloride and Calcium Chloride projects, which are currently in pre-commissioning trials, as these will drive future value-chain integration.
Q1 FY27 PAT Surges to Rs 693 Cr (Adjusted Rs 147 Cr); Chemicals Revenue Up 33%
DCM Shriram reported a 9% YoY revenue growth to Rs 3,564 Cr for Q1 FY27, led by a robust 33% growth in the Chemicals segment. While reported PAT jumped 509% to Rs 693 Cr, this was primarily due to a one-time tax adjustment of Rs 474.3 Cr and exceptional gains; normalized PAT stood at Rs 147 Cr (up ~29% YoY). The Chemicals business benefited from a 7% rise in ECU realizations and new value-chain contributions, while the Bioseed segment faced a 26% revenue decline due to erratic monsoons. The company is transitioning from a heavy capex cycle to a commissioning phase, with several downstream projects expected to go live in Q2 FY27.
Confidence: HIGH
What changedThe company has moved into the commissioning phase of its major capex cycle and recognized a significant one-time tax benefit from a favorable court ruling.
Why it mattersThe strong performance in Chemicals and Fenesta is successfully offsetting volatility in the Agri-businesses, demonstrating the benefit of the company's diversified and integrated model.
Q1 FY27 Revenue: Rs 3,564 CrNormalized PAT: Rs 147 CrOne-time Tax Adjustment: Rs 474.3 CrChemicals Revenue Growth: 33%Net Debt: Rs 1,649 CrQ1 Revenue vs TTM Revenue: ~27%
📅 Short termThe stock may see positive sentiment due to the strong operational beat in the Chemicals segment and the large reported PAT figure, despite the one-time nature of the tax gain.
📈 Long termStructural growth is expected as the company integrates deeper into the chemical value chain (Epoxy, AlCl3) and expands its consumer-facing Fenesta brand.
⚠ Risk flags
- Erratic monsoon impacting agri-input demand
- High energy costs (Gas at $15.5/mmbtu)
- Regulatory risks regarding ethanol blending feedstock
Key Highlights
Chemicals segment revenue grew 33% YoY to Rs 1,205 Cr, driven by 7% higher ECU and new product contributions.
Reported PAT of Rs 693.4 Cr includes a Rs 474.3 Cr favorable tax judgment and Rs 79.4 Cr gain from land/JV stake sale.
Fenesta Building Systems delivered 22% revenue growth to Rs 303 Cr with a 4% increase in the order book.
Bioseed revenue declined 26% YoY to Rs 210 Cr due to delayed rainfall impacting Kharif sowing demand.
Net Debt stood at Rs 1,649 Cr as of June 2026, compared to Rs 1,481 Cr in the previous year.
👀 What to Watch
Monitor the capacity ramp-up of the newly commissioned Epichlorohydrin plant and the upcoming Aluminum Extrusion and Chloride projects in Q2 FY27. Investors should also track global caustic soda price trends and any government policy shifts regarding ethanol feedstock pricing.
Q1 FY27: DCM Shriram PAT jumps 509% to ₹693 Cr on tax gains; Chemicals revenue up 33%
DCM Shriram reported a 9% YoY revenue growth to ₹3,564 Cr for Q1 FY27, primarily driven by a robust 33% surge in the Chemicals segment. While reported PAT soared 509% to ₹693.4 Cr, this was heavily influenced by a ₹474.3 Cr one-time tax adjustment and a ₹79.4 Cr exceptional gain; normalized PAT stood at ₹147 Cr. The Chemicals business benefited from a 7% rise in ECU and new contributions from the Epoxy value chain. Conversely, the Bioseed segment saw a 26% revenue decline due to erratic monsoons impacting Kharif sowing.
Confidence: HIGH
What changedThe company is transitioning from a heavy capex phase to a commissioning phase, with significant one-time tax benefits boosting the current quarter's bottom line.
Why it mattersThe strong performance in Chemicals and Fenesta indicates successful diversification into higher-margin downstream products, reducing the company's historical dependence on volatile agri-commodity cycles.
Q1 Revenue: ₹3,564 CrNormalized PAT: ₹147 CrChemicals Revenue Growth: 33%Tax Adjustment Gain: ₹474.3 CrNet Debt: ₹1,649 CrQ1 Revenue vs TTM Revenue: 26.9%
📅 Short termThe headline PAT growth may drive positive sentiment, though the market will likely adjust for the one-time tax gains. Operational strength in Chemicals is a key positive.
📈 Long termStructural shift towards Advanced Materials (Epoxy/ECH) and Fenesta expansion provides a more stable and higher-margin profile over the next 2-3 years.
⚠ Risk flags
- Erratic monsoon impacting Bioseed and Fertilizer demand
- High energy costs (Gas at $15.5/mmbtu)
- Regulatory uncertainty regarding ethanol feedstock pricing
Key Highlights
Chemicals segment revenue grew 33% YoY to ₹1,205 Cr, supported by a 7% increase in Electrochemical Unit (ECU) realizations.
Reported PAT of ₹693.4 Cr includes a ₹474.3 Cr favorable tax judgment and ₹79.4 Cr profit from land/stake sales.
Fenesta Building Systems delivered 22% revenue growth to ₹303 Cr with a 4% increase in the order book.
Bioseed revenue fell 26% YoY to ₹210 Cr, resulting in a PBDIT loss of ₹9 Cr due to delayed rainfall.
Net Debt stood at ₹1,649 Cr as of June 2026, compared to ₹1,481 Cr in the previous year.
👀 What to Watch
Monitor the capacity ramp-up of the newly commissioned Epichlorohydrin plant and the upcoming Aluminium Extrusion plant in Q2 FY27. Watch for stabilization in the Bioseed segment following the late monsoon recovery.
DCM Shriram Q1 FY27 Results: Subsidiaries Contribute Rs 179.46 Cr Revenue
DCM Shriram approved its Q1 FY27 results for the quarter ended June 30, 2026. The auditor's report highlights that 14 subsidiaries contributed Rs 179.46 crore to revenue and Rs 6.34 crore to net profit, which is a relatively small portion (~1.4%) of the company's TTM revenue of Rs 13,232 crore. A structural change occurred as Shriram Teknor Limited transitioned from a subsidiary to a joint venture effective April 17, 2026. The company continues to focus on its diversified segments including Chemicals, Sugar, and the Fenesta brand.
Confidence: HIGH
What changedThe company has formally reported its Q1 FY27 financial performance and reclassified Shriram Teknor Limited from a subsidiary to a joint venture.
Why it mattersAs a diversified mega-cap, these results provide the first health check for the new fiscal year, showing the scale of subsidiary operations and structural changes in the group's entity holdings.
Subsidiary Revenue (Q1): Rs 179.46 crSubsidiary PAT (Q1): Rs 6.34 crSubsidiary Revenue vs TTM Revenue: ~1.36%JV Transition Date: April 17, 2026
📅 Short termThe stock may see neutral to range-bound movement as the subsidiary contribution is minor; the market will focus on the core parent company's operational margins.
📈 Long termLong-term value depends on the successful scaling of the HSCL acquisition (Epoxy/Advanced Materials) and the capacity expansions at the Bharuch chemical plant.
⚠ Risk flags
- Regulatory restrictions on ethanol blending
- Coal price volatility impacting Chloro-Vinyl margins
Key Highlights
14 subsidiaries and 2 consolidated entities contributed Rs 179.46 crore to the Q1 FY27 revenue.
Net profit from these reviewed subsidiaries stood at Rs 6.34 crore for the quarter ended June 30, 2026.
Shriram Teknor Limited (formerly Shriram Polytech) became a Joint Venture effective April 17, 2026.
The Board meeting for result approval concluded at 3:35 P.M. on July 28, 2026.
👀 What to Watch
Investors should examine the full segment-wise P&L to assess the performance of the Chloro-Vinyl and Sugar divisions, specifically looking for the impact of coal price volatility on margins.
DCM Shriram signs 58 MW Renewable Energy deal; Rs 104.4 Cr investment for 26% SPV stake
DCM Shriram has entered into a definitive agreement with Serentica Renewables to source 58 MW of hybrid renewable power for its Bharuch facility. The company will invest Rs 104.4 crore for a 26% equity stake in the project SPV to comply with captive power regulations. This initiative will increase the company's total renewable capacity to 176 MW across its Bharuch and Kota sites. The project is slated for commissioning by June 30, 2027, and is expected to mitigate 0.4 million tonnes of CO2 emissions annually while stabilizing long-term power costs.
Confidence: HIGH
What changedThe company has moved from board approval to signing a definitive agreement for a captive renewable energy project in Gujarat.
Why it mattersPower is a critical input cost for the energy-intensive Chlor-alkali business; this deal secures long-term pricing and improves the company's ESG profile.
Investment Value: Rs 104.4 croreInvestment vs Net Worth: 1.35%Renewable Capacity: 58 MWTotal Group RE Capacity: 176 MWCommissioning Deadline: 30th June 2027
📅 Short termPositive sentiment is expected as the company executes its strategy to lower operational costs and meet sustainability targets.
📈 Long termStructurally improves the cost-competitiveness of the Chemicals segment and reduces exposure to volatile conventional energy prices.
⚠ Risk flags
- Project execution delays beyond June 2027
- Regulatory changes in captive power generation norms
Key Highlights
Investment of Rs 104.4 crore for a 26% equity stake in Serentica Renewables India 38 Pvt Ltd
Sourcing of 58 MW peak hybrid renewable power (36 MW round-the-clock) for the Bharuch plant
Total renewable power capacity to reach 176 MW across Bharuch and Kota sites upon completion
Projected commissioning date for the hybrid renewable energy project is June 30, 2027
Estimated annual reduction of 0.4 million tonnes of CO2 emissions through this green energy shift
👀 What to Watch
Monitor the commissioning progress towards the June 2027 deadline and observe the impact on power costs in the Chemicals segment margins in future quarterly results.
Rs 104.4 Cr Investment for 26% Stake in Serentica SPV to Secure 58 MW Renewable Power
DCM Shriram has entered into a definitive agreement to invest Rs 104.4 crore for a 26% equity stake in Serentica Renewables India 38 Private Limited. This strategic move secures ~58 MW of hybrid renewable power (~36 MW round-the-clock) for its energy-intensive Bharuch chemical plant. The project, expected to be commissioned by June 30, 2027, will increase the company's total renewable capacity to 176 MW across its Bharuch and Kota sites. This investment aims to reduce exposure to volatile conventional energy prices and lower carbon emissions by 0.4 million tonnes annually.
Confidence: HIGH
What changedDCM Shriram has transitioned from board approval to a definitive agreement for a captive renewable power source through a 26% stake in a Serentica Renewables SPV.
Why it mattersPower is a primary cost driver for the Chlor-alkali business; securing captive renewable energy provides long-term cost visibility and improves the company's ESG profile by reducing carbon intensity.
Investment Amount: Rs 104.4 croreEquity Stake: 26%Power Capacity: 58 MWInvestment vs Net Worth: ~1.35%Commissioning Deadline: June 30, 2027
📅 Short termThe announcement is likely to be viewed positively as a step toward cost-efficiency, though financial impact will only materialize post-2027.
📈 Long termStructurally strengthens the Chemicals segment by hedging against rising grid power tariffs and aligning with global decarbonization trends.
⚠ Risk flags
- Project execution and commissioning delays
- Regulatory changes in group captive power regulations
Key Highlights
Investment of Rs 104.4 crore to acquire a 26% equity stake in a renewable energy SPV
Secures ~58 MW of additional renewable power for the Bharuch unit, bringing total group capacity to 176 MW
Projected to avoid approximately 0.4 million tonnes of CO2 emissions annually
Target commissioning date for the renewable power project is June 30, 2027
Investment represents approximately 1.35% of the company's current net worth of Rs 7,706 crore
👀 What to Watch
Investors should monitor the execution timeline leading up to the June 2027 commissioning and observe the subsequent impact on power costs within the Chemicals segment margins.
Rs 172.82 Cr tax relief granted to DCM Shriram by ITAT for AY 2022-23
DCM Shriram has received a favorable order from the Income-tax Appellate Tribunal (ITAT), New Delhi, regarding a material tax dispute for AY 2022-23. The ITAT granted relief on a tax effect of Rs 172.82 crore out of a total addition-related tax effect of Rs 178.24 crore. This effectively challenges a previous demand of Rs 249.27 crore raised by the Assessing Officer (AO) in October 2025. The company will now seek a formal deletion of the demand and correction of MAT credit computational errors as directed by the tribunal.
Confidence: HIGH
What changedA significant tax dispute for AY 2022-23 has been largely resolved in favor of the company by the ITAT, reducing a potential liability.
Why it mattersThe relief amount of Rs 172.82 crore is substantial, representing approximately 20.6% of the company's TTM PAT of Rs 838 crore, thus protecting cash flows and reducing contingent liabilities.
Relief granted (Tax effect): Rs 172.82 crOriginal demand amount: Rs 249.27 crRelief vs TTM PAT: 20.62%Tax effect referred back to AO: Rs 5.42 crAssessment Year: 2022-23
📅 Short termThe news is likely to be viewed positively by the market as it removes the immediate threat of a large tax payout.
📈 Long termLimited structural impact, but demonstrates the company's ability to successfully defend its tax positions in higher tribunals.
⚠ Risk flags
- Potential for Income Tax Department to appeal the ITAT order in the High Court
Key Highlights
ITAT granted tax relief of Rs 172.82 crore for Assessment Year 2022-23.
The original demand raised by the Assessing Officer was Rs 249.27 crore.
Only a minor tax effect of Rs 5.42 crore has been referred back to the AO for reconsideration.
ITAT directed the AO to correct computational errors regarding the set-off of brought forward MAT Credit.
The company received the formal order on July 3, 2026, following a stay order previously granted in February 2026.
👀 What to Watch
Investors should monitor the final 'order giving effect' from the Assessing Officer to confirm the formal deletion of the Rs 249.27 crore demand and any potential appeals by the Tax Department in higher courts.
Timeline Extended to Dec 31, 2026, for Acquisition of Four Industrial Salt Companies
DCM Shriram has announced a six-month extension for the 100% equity acquisition of four industrial salt companies, moving the target completion date from June 2026 to December 31, 2026. The delay is attributed to pending conditions precedent and necessary regulatory approvals. This strategic move is intended to secure approximately 13% of the company's internal salt requirements, supporting its Chlor-Alkali (Chemicals) business. While the delay postpones vertical integration benefits, the fundamental intent of the acquisition remains intact.
Confidence: HIGH
What changedThe completion date for the acquisition of four salt companies has been pushed back by six months from the original June 2026 target.
Why it mattersSecuring 13% of internal salt requirements provides better raw material security and cost control for the company's Chemicals segment, which is a key profit driver.
Extended Completion Date: 31st December 2026Original Completion Date: June 2026Internal Salt Requirement Coverage: 13%Equity Stake to be Acquired: 100%Number of Target Companies: 4
📅 Short termThe delay is unlikely to have a material impact on the stock price in the immediate weeks as it is a procedural extension.
📈 Long termSuccessful integration will strengthen the company's vertical integration in the Chlor-Alkali chain, though the benefits are now deferred to late FY27.
⚠ Risk flags
- Regulatory approval delays
- Execution risk in integrating four separate entities
Key Highlights
Acquisition involves 100% equity share capital of four companies producing and selling industrial salt
Completion timeline extended from June 2026 to December 31, 2026
Strategic goal is to secure 13% of internal salt requirements for chemical operations
Delay is due to pending conditions precedent and necessary regulatory approvals
👀 What to Watch
Watch for the final completion announcement by December 2026 and monitor management commentary on how this vertical integration impacts Chlor-Alkali margins in 2027.
DCM Shriram Approves Addl. Rs 18 Cr Investment for 10 MW Renewable Power at Bharuch Plant
DCM Shriram's Board has approved an additional equity investment of Rs. 18 crores to secure an extra 10 MW of renewable power for its Bharuch facility. This brings the total approved investment for renewable power Special Purpose Vehicles (SPVs) to Rs. 105 crores, targeting a total additional supply of 58 MW. Once completed, the Bharuch Plant's total renewable power capacity will reach approximately 108 MW. The company intends to maintain a minimum 26% equity stake in these SPVs to ensure captive power status.
Key Highlights
Approved additional equity investment of Rs. 18 crores for renewable power supply.
Total approved investment for renewable power SPVs increased to Rs. 105 crores.
Additional renewable power supply capacity raised from 48 MW to 58 MW.
Total renewable power supply for the Bharuch Plant to reach approximately 108 MW.
Company to maintain a minimum 26% equity stake in the SPVs for the power supply.
👀 What to Watch
Investors should view this as a positive step toward operational cost reduction and ESG compliance. No immediate action is required, but the move strengthens the company's long-term sustainability profile.
DCM Shriram Approves Additional ₹18 Cr Investment for Renewable Power; Total ₹105 Cr
DCM Shriram's Board has approved an additional equity investment of ₹18 crores to secure an extra 10 MW of renewable power for its Bharuch plant. This follows a previous approval of ₹87 crores, bringing the total investment to ₹105 crores for a combined 58 MW of renewable capacity via SPVs. The company aims to reach a total renewable power supply of approximately 108 MW at the Bharuch facility. The investment ensures a minimum 26% equity stake in the Special Purpose Vehicles involved.
Key Highlights
Approved additional equity investment of ₹18 crores for renewable power procurement.
Total equity investment for renewable SPVs increased from ₹87 crores to ₹105 crores.
Secures an additional ~10 MW, bringing the total new renewable capacity to ~58 MW.
Total renewable power supply for the Bharuch plant will increase to ~108 MW.
Investment involves maintaining a minimum 26% equity stake in one or more SPVs.
👀 What to Watch
Investors should view this as a positive move towards long-term energy cost reduction and ESG compliance. Monitor the impact of these renewable projects on the Bharuch plant's operating margins once fully commissioned.
DCM Shriram Q4 FY26 Revenue Up 11% to ₹3,193 Cr; PBDIT Dips to ₹400 Cr
DCM Shriram reported an 11% year-on-year growth in Q4 FY26 revenue reaching ₹3,193 crore, driven largely by a 32% surge in the Chemicals segment. However, PBDIT saw a slight decline to ₹400 crore from ₹426 crore in the previous year due to margin pressures in Vinyl and Sugar segments. The company successfully commissioned its ECH plant in April 2026 and announced a strategic 50:50 JV with Teknor Apex for its plastics compounding business. Management is focusing on expansion with ₹318 crore in new capex approvals for renewable energy and epoxy resins.
Key Highlights
Q4 FY26 Net Revenue grew 11% YoY to ₹3,193 crore, while PBDIT stood at ₹400 crore.
Chemicals revenue jumped 32% YoY; ECH plant fully commissioned in April 2026.
Board approved ₹318 crore capex for renewable power (₹217 Cr) and epoxy resin expansion (₹101 Cr).
Sugar segment faced challenges with a lower crush of 473 lakh quintals despite a 10.8% recovery rate.
Formed a 50:50 JV with Teknor Apex B.V. for Shriram Polytech Limited to boost plastic compounding.
👀 What to Watch
Investors should monitor the ramp-up of the newly commissioned ECH plant and the impact of the Teknor Apex JV on margins. The shift towards renewable energy and value-added chemicals provides a positive long-term outlook despite short-term volatility in sugar and vinyl prices.
DCM Shriram Recommends Rs 4 Final Dividend and Announces Rs 101 Cr Chemicals Expansion
DCM Shriram has reported its audited FY26 results and recommended a final dividend of Rs 4 per share, bringing the total annual payout to Rs 11.20 per share. The company is aggressively expanding its Advanced Materials segment through a Rs 101 crore investment in its subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL). This investment aims to increase Formulated Resins capacity by 36,000 TPA, reaching a total of 50,000 TPA. Additionally, the board has approved the cancellation of 3.9 million forfeited equity shares, subject to shareholder approval.
Key Highlights
Recommended final dividend of 200% (Rs 4 per share), totaling 560% (Rs 11.20 per share) for FY26.
Approved Rs 101 crore capital expenditure for subsidiary HSCL to add 36,000 TPA of Formulated Resins capacity.
Total Formulated Resins capacity to reach 50,000 TPA following the expansion project.
Board approved financial assistance of up to Rs 100 crore to HSCL through a mix of equity and debt.
Proposed cancellation of 39,00,000 forfeited equity shares of face value Rs 2 each.
👀 What to Watch
Investors should note the company's focus on the high-growth Advanced Materials segment and its commitment to shareholder returns through a healthy dividend yield. The expansion project signals long-term growth potential in the chemicals business.
DCM Shriram FY26 PAT Jumps 42% to ₹856 Cr; Board Recommends 200% Final Dividend
DCM Shriram reported a resilient FY26 with consolidated revenue growing 12% to ₹14,264 crore and PAT surging 42% to ₹856 crore. The bottom line was significantly bolstered by a one-time deferred tax credit of ₹239 crore, though operational PBDIT also grew a healthy 15% to ₹1,694 crore. Growth was primarily driven by the Chemicals segment, Shriram Farm Solutions, and a milestone performance by Fenesta Building Systems. The company continues its strategic shift toward advanced materials with the commissioning of its ECH plant and new acquisitions in the resins space.
Key Highlights
Consolidated FY26 PAT reached ₹856 crore (+42% YoY), including a one-time deferred tax credit of ₹239 crore.
Fenesta Building Systems crossed the ₹1,100 crore revenue milestone, growing 28% with an order book of ₹1,498 crore.
Chemicals business saw 12% growth in caustic soda volumes and commissioned a 52,000 TPA Epichlorohydrin (ECH) plant in April 2026.
Shriram Farm Solutions revenue increased 18% to ₹1,689 crore, led by record sales in the Research Wheat segment.
Board recommended a final dividend of 200%, bringing the total dividend for the year to 560%.
👀 What to Watch
Investors should focus on the strong operational growth in the Chemicals and Fenesta segments, which are offsetting pressures in the Sugar business. The stock remains attractive for long-term holders given the aggressive expansion into high-margin advanced materials and consistent dividend payouts.
DCM Shriram FY26 PAT Jumps 42% to ₹856 Cr; Total Dividend Declared at 560%
DCM Shriram reported a solid FY26 with revenue growing 12% to ₹13,538 crore and PAT rising 42% to ₹856 crore, supported by a ₹239 crore deferred tax credit. The Chemicals segment was a standout performer with 38% revenue growth following capacity expansions, while Fenesta Building Systems grew 28%. The company is pivoting towards advanced materials with the commissioning of its Epichlorohydrin plant in April 2026. A final dividend of 200% has been recommended, totaling 560% for the full year.
Key Highlights
FY26 Consolidated Revenue reached ₹13,538 crore (up 12% YoY) and PBDIT stood at ₹1,694 crore (up 15% YoY).
Chemicals revenue surged 38% to ₹3,832 crore in FY26, driven by a 12% volume growth in Caustic Soda.
Fenesta Building Systems achieved 28% revenue growth with a strong year-end order book of ₹1,498 crore.
Commissioned 52,000 TPA Epichlorohydrin plant in April 2026 to strengthen the advanced materials value chain.
Total dividend for FY26 stands at 560% (₹11.20 per share) following a final dividend recommendation of 200%.
👀 What to Watch
The company's diversification into high-margin advanced materials and strong growth in the Fenesta segment offset cyclicality in the sugar business. Long-term investors should monitor the utilization levels of newly commissioned chemical capacities.
DCM Shriram Recommends Rs 4 Final Dividend, Cancels 39L Forfeited Shares & Plans Rs 101 Cr Capex
DCM Shriram has recommended a final dividend of Rs 4 per share, bringing the total dividend for FY26 to Rs 11.20 per share (560%). The board also approved the cancellation of 39,00,000 forfeited equity shares, subject to shareholder approval. Furthermore, the company's subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), will undertake a Rs 101 crore capital expenditure to expand its Formulated Resins capacity by 36,000 TPA. DCM Shriram will provide financial assistance of up to Rs 100 crore to HSCL through a mix of equity and debt to support this growth.
Key Highlights
Recommended final dividend of 200% (Rs 4 per share), totaling Rs 11.20 for the full financial year.
Proposed cancellation of 39,00,000 forfeited equity shares of face value Rs 2 each.
Subsidiary HSCL to invest Rs 101 crores to increase Formulated Resins capacity from 14K TPA to 50K TPA.
DCM Shriram to provide financial assistance of up to Rs 100 crores to HSCL for the expansion.
The 37th Annual General Meeting (AGM) is scheduled for August 18, 2026.
👀 What to Watch
Investors should note the healthy total dividend yield and the company's strategic focus on expanding its Advanced Materials portfolio. The expansion in chemicals capacity signals long-term growth potential in higher-margin segments.
DCM Shriram Recommends Rs 4 Final Dividend; Plans Rs 101 Cr Expansion in Chemicals
DCM Shriram has announced a final dividend of Rs 4 per share, bringing the total dividend for FY26 to Rs 11.20 (560% of face value). The company is expanding its specialty chemicals footprint through its subsidiary HSCL with a Rs 101 crore investment to add 36,000 TPA of Formulated Resins capacity. Additionally, the board has approved the cancellation of 3.9 million forfeited equity shares, subject to shareholder approval. To support the expansion, the company will provide financial assistance of up to Rs 100 crore to its subsidiary.
Key Highlights
Recommended final dividend of Rs 4 per share, totaling Rs 11.20 for the full financial year 2025-26
Approved Rs 101 crore capital expenditure for subsidiary HSCL to increase Formulated Resins capacity by 36K TPA
Total Formulated Resins capacity to reach 50K TPA upon completion of the expansion project
Cancellation of 39,00,000 forfeited equity shares of Rs 2 each approved by the board
Financial assistance of up to Rs 100 crore approved for HSCL through a mix of equity and debt
👀 What to Watch
Investors should find the high dividend payout and the strategic expansion into high-margin specialty chemicals encouraging. The stock remains a watch for long-term growth in the advanced materials segment.
DCM Shriram FY26 Results: Total Dividend of Rs 11.20/Share and Rs 101 Cr Capex for Subsidiary
DCM Shriram has announced its FY26 audited results along with a final dividend recommendation of Rs 4 per share, bringing the total annual payout to Rs 11.20 per share (560%). The company is aggressively expanding its chemicals portfolio with a Rs 101 crore capex plan for its subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), to increase Formulated Resins capacity by 36,000 TPA. To support this, DCM Shriram will provide financial assistance of up to Rs 100 crore to HSCL. Additionally, the board has proposed the cancellation of 3.9 million forfeited equity shares, pending shareholder approval.
Key Highlights
Recommended final dividend of Rs 4 per share (200%), making the total FY26 dividend Rs 11.20 per share.
Approved Rs 101 crore capex for subsidiary HSCL to expand Formulated Resins capacity from 14K TPA to 50K TPA.
Committed up to Rs 100 crore in financial assistance to HSCL through a mix of equity and debt.
Proposed cancellation of 39,00,000 forfeited equity shares of face value Rs 2 each.
The 37th Annual General Meeting is scheduled for August 18, 2026, to seek shareholder approvals.
👀 What to Watch
Investors should find the high dividend payout and the strategic expansion into advanced chemical materials encouraging for long-term value. Monitor the execution of the capacity expansion at HSCL as it scales the chemicals business.
